SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing extreme volatility and a parabolic rally driven by intense speculative interest, aggressive price target hikes from analysts, and widespread community discussion regarding a potential stock split. While bulls point to high demand for AI-related storage as a justification for the surge, many market participants are debating whether the rapid valuation increase is a sustainable trend or an overextended bubble prone to a sharp reversal.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently experiencing heightened volatility following a now-deleted social media critique by investor Michael Burry, who suggested that Anthropic's AI agents pose a significant threat to Palantir's market share. While the broader community remains fiercely divided between long-term bulls highlighting Palantir's unmatched AIP moat and skeptics questioning its high valuation, the intense discussion reflects broader market anxiety regarding the future of enterprise software versus agentic AI.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow ($NOW) is facing intense selling pressure as investors grapple with concerns regarding AI-driven disruption and sector-wide budget constraints, despite management's recent insider buying and positive long-term growth outlooks. The community remains deeply divided, with some viewing the current price action as an overreaction to 'AI fear' and a generational buying opportunity, while others warn of a structural decline in the traditional software business model.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is seeing intense community debate as the stock experiences extreme volatility driven by a massive surge in AI hyperscaler demand, leading to reports of the company being sold out of capacity through 2028. While retail traders are capitalizing on its parabolic momentum, vocal skeptics and short sellers argue that the company's valuation has detached from its fundamental revenue and cash flow, labeling the current price action an AI-driven bubble.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is seeing intense retail focus following an earnings report that highlighted a disconnect between sluggish top-line revenue and a massive, record-breaking backlog. The community is sharply divided, with bulls pointing to the company's critical role in AI semiconductor testing as a reason for long-term growth, while skeptics are calling for a correction, citing high valuations and recent insider selling as major red flags.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing extreme volatility and intense community focus following the announcement of a major upsized order for its 800G transceivers from a key hyperscale customer. While some market participants express skepticism toward the company's valuation and manufacturing execution, bullish investors are leaning into the narrative that photonics infrastructure remains a mission-critical bottleneck for AI, fueling expectations for further price appreciation.

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on April 27, 2023 and is headquartered in New York, NY.

Aimei Health Technology Co Ltd

Aimei Health Technology is experiencing extreme volatility driven by high-conviction retail momentum and short-squeeze speculation typical of low-float SPACs. Community members are actively debating its potential for multi-day rallies, comparing it to other high-momentum movers while warning of the inherent risks associated with rapid, catalyst-driven price swings.

Shake Shack, Inc. engages in the operation and licensing of Shake Shack restaurants which serve burgers, hot dogs, crinkle cut fries, shakes, frozen custard, beer, wine, and related products. The company was founded by Daniel Harris Meyer on September 23, 2014 and is headquartered in New York, NY.

Shake Shack Inc - Ordinary Shares - Class A

Shake Shack is trending following a Mizuho upgrade to Outperform, with the analyst citing robust same-store sales potential, operational efficiencies, and upcoming marketing catalysts as key drivers for growth. Community members are actively debating the stock's high valuation relative to its growth trajectory, with some expressing skepticism regarding its premium positioning in a challenged consumer environment while others highlight potential long-term EBITDA expansion.

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

Dash is experiencing significant momentum driven by rumors of a major partnership with POL and the broader resurgence of interest in privacy-focused assets following recent performance in peer tokens like Zcash. The community is actively discussing potential breakout levels and the asset's utility, with many traders optimistic that the privacy sector is entering a period of renewed market attention.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad is capturing significant community attention as a high-performance Layer-1 blockchain, with investors increasingly optimistic about its potential to compete with established networks. Traders are actively discussing the benefits of staking for high yields while betting on long-term growth and its eventual ascension to higher price levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know

AC Immune stock gains after expansion of its agreement with LLY, adding next-generation Tau Morphomer candidates and boosting long-term Alzheimer's strategy.

Soleno Therapeutics Stock Rallies 56.4% in a Week: Here's Why

SLNO shares surge as Neurocrine inks $2.9B cash deal to acquire it at $53 a share, adding Vykat XR and expanding its rare disease and endocrinology portfolio.

SNY's Lunsekimig Succeeds in Asthma & CRSwNP Studies, Fails in Eczema

Sanofi posts strong mid-stage results for lunsekimig in asthma and CRSwNP but a setback in atopic dermatitis clouds the broader clinical picture.

IMVT Stock Falls 2.4% as Batoclimab Misses Late-Stage Study Endpoints

Immunovant slips 2.4% after batoclimab misses key phase III endpoints in thyroid eye disease trials, despite stable safety and signs of biological activity.

RARE Rises as FDA Accepts Resubmitted BLA for Sanfilippo Syndrome

Ultragenyx Pharmaceutical jumps 5% as the FDA accepts UX111 BLA resubmission, setting up a September 2026 decision for a potential first treatment for MPS IIIA.

Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics and Avalo Therapeutics

Small drug stocks like Indivior gain traction as biotech recovery strengthens, fueled by innovation, M&A activity, and promising pipeline developments.

OCGN Completes Early Enrollment in Pivotal Stargardt Disease Study

Ocugen completes GARDian3 enrollment early as OCU410ST gene therapy targets Stargardt disease with no approved treatments. Data readouts are expected in Q3. 

5 Small Drug Stocks to Buy as Sector Recovery Gains Strength

Innovation is at its peak in the Zacks Medical-Drugs industry. INDV, CPRX, TBPH, RLMD and AVTX may prove to be good additions to one's portfolio.

Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus

KOD posts wider Q4 loss. However, its pipeline advances, with strong phase III data for Zenkuda driving accelerated regulatory plans.

AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD

Agios Pharmaceuticals jumps 14% as it moves toward accelerated FDA approval for mitapivat in sickle cell disease after key regulatory feedback.

Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company was founded on December 23, 2014 and is headquartered in North Chesterfield, VA.

Current Price	$32.31
Prev Close	$31.94
Open	$31.79
Dividend Yield	0.00%
50-Day Moving Average	$32.35
Beta	0.82
Avg. Volume	3.7M
PE Ratio	19.46

52-Week High	$38.00
52-Week Low	$8.69
Market Capitalization	$3.99B
EPS (Annual)	$1.64
Price to Book	-41.21
Revenue Per Employee	$1.48M

INDV
Indivior Plc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INDV News

INDVIndivior Plc